Pose-estimation gait features classify sarcopenia in musculoskeletal patients
Source check: Source checked. Not independent scientific confirmation.
Finding: BlazePose video landmarks and smart-insole gait measures supported sarcopenia classification in 83 musculoskeletal patients, including 23 classified using AWGS criteria. Random forest, support vector and neural models were evaluated after a patient-level train/test split. Some combinations performed strongly in this small internal sample, but external diagnostic accuracy and benefits for patient management were not established.
Technology: MediaPipe BlazePose; random forest; support vector machine; artificial neural network
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- CNN-based BlazePose extracts joint landmarks; learned classifiers combine gait variables and insole measurements to distinguish reference sarcopenia groups.
- Test and result
- Patient-level internal split in an 83-person cohort with clinical AWGS-based reference classification.
- Limitation / still unknown
- Small-sample performance stability, external validation and clinical benefit remain unestablished.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10751435/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary full paper relevant model Methods, study Results and limitations; exact primary front-matter identity and Europe PMC metadata checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.